After Success Against COVID-19 Variants, Novavax Will File Vaccine First In UK
Efficacy Lower Against South Africa Strain
THE TRIALS IN THE UK AND SOUTH AFRICA MEANT NOVAVAX IS THE FIRST TO TEST A VACCINE AGAINST THE NEW SARS-COV2 VARIANTS FIRST IDENTIFIED IN THESE COUNTRIES.
